MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Regulation FD Disclosure

33

MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Regulation FD Disclosure
ITEM 7.01

REGULATION FD DISCLOSURE.

On August 24, 2017, MabVax Therapeutics Holdings, Inc. (the “Company”) updated and made available its corporate presentation. The presentation is attached hereto as Exhibit 99.1.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

(d)Exhibits.

The exhibit listed in the following Exhibit Index is furnished with this Current Report on Form 8-K.

Exhibit No.

Description

99.1

Power Point Presentation dated August 2017


MABVAX THERAPEUTICS HOLDINGS, INC. Exhibit

To view the full exhibit click here

An ad to help with our costs